Building Your Care Team & First Visit Prep

Because atypical Chronic Myeloid Leukemia (aCML) is ultra-rare—affecting only about 3 out of every 10 million people—your care team’s experience is one of the most important factors in your journey ^[1][2]. Many local oncologists may see only one case of aCML in their entire career ^[3].

For a disease this complex, “standard care” often means seeking out a team that specializes specifically in MDS/MPN overlap syndromes ^[4][5].

Your Specialized Care Team

A comprehensive team for aCML should go beyond a general oncologist. Ideally, your care should be coordinated by a multidisciplinary group at an academic research center or experienced leukemia clinic:

• MDS/MPN Specialist: A hematologist-oncologist who focuses specifically on overlap syndromes and understands the unique biology of aCML ^[4].
• Expert Hematopathologist: A doctor who specializes in looking at blood and bone marrow. This is critical because aCML is complex; in one Polish registry survey, when strict criteria were applied upon expert review, the classification changed for over 60% of the initially reported cases ^[3][5]. This highlights why having specialists look at your case is essential.
• Transplant Physician (BMT): Because an allogeneic stem cell transplant is the only established potentially curative option, experts recommend meeting with a transplant team early—often shortly after diagnosis—to begin donor searching and health optimization ^[6][7].

The Second Opinion “Briefcase”

When you visit a specialist for a second opinion, they will need to see the actual finalized reports of your disease, not just the summaries. You (or your current doctor’s office) should gather the following physical and digital artifacts:

1. Bone Marrow Slides and Pathology Report: Request the physical glass slides from your biopsy and the complete marrow report, as the specialist’s pathologist will want to review them ^[8].
2. Finalized Molecular and Cytogenetic Reports: The completed reports from your NGS panel, flow cytometry, and cytogenetics ^[9][10].
3. CBC History: A spreadsheet or printout of your Complete Blood Count (CBC) and differential trends over the last 3–6 months. Seeing how your blood counts are changing is very important ^[5].
4. Spleen Imaging and Medication History: Any ultrasound or CT scan reports that document the size of your spleen, along with a full medication history ^[5][11].

The Role of Self-Advocacy

Navigating a rare diagnosis requires a high level of self-advocacy. You may find yourself in the position of educating your local providers or pushing for more advanced testing ^[3].

If your local doctor is hesitant about a second opinion, remember that in rare diseases, seeking expert consultation is considered standard practice and is welcomed by most specialists ^[4]. Your goal is to create a “hub-and-spoke” model of care: an expert at an experienced leukemia center (the hub) providing the strategy, while your local oncologist (the spoke) manages the day-to-day treatments and monitoring.

Finding Clinical Trials

Because standard treatments for aCML are limited, you should ask an expert center about appropriate clinical trials at diagnosis and throughout your care ^[4][12]. While not a universal requirement, trials offer access to investigational approaches. Eligibility, travel, and trial risks must be weighed carefully against the need for urgent disease control or transplant evaluation ^[12]. 🔍